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Abstract
Dynamic issues associated with infection create unprecedented demands for quality
healthcare improvements and modifications. Researchers found extended antibiotic
infusions to be an effective treatment option with significant clinical benefits to patients
and astounding cost savings. This scholarly project identified the emergence of several
clinical issues threatening to undermine the intended patient responses to extended
antibiotic infusion therapy in one large hospital system.
Problem: Unrecognized infusion delays and short infusion durations created the need for
an educational pilot initiative to improve the administration process of
piperacillin/tazobactam on one nursing unit.
Intervention: Nurses on the pilot unit received instruction regarding the
pharmacodynamics of time-dependent antibiotics and the infusion management of dead
space volumes. Random infusions were monitored post instruction for consistency and
accuracy.
Results: Of the 73 nurses who were emailed a self-instruction module, a total of 30
(41%) nurses submitted an attestation for completing the instruction. Each nurse
completing the instruction responded 100% correctly to all five post-test questions (150
questions/150 correct). Of the randomly observed post-instruction infusions, 17 of 29
pumps (59%) were programmed to infuse according to the instruction. Infusions
programmed for 100% of the duration ordered increased from zero to 59% post
instruction. The difference in minimum inhibitory concentration (MIC) pre and post
instruction demonstrated a 72% improvement in the therapeutic duration delivery of
piperacillin/tazobactam.
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Conclusion: The educational intervention, designed to redefine the beginning of the
extended antibiotic infusion, was recommended as a sustainable solution to this practice
problem.
Keywords: extended antibiotic infusions, prolonged antibiotic infusions,
piperacillin/tazobactam, stewardship, smart pump, dead space volume, infusion
management, quality improvement
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SECTION I
Problem Recognition and Significance
Introduction
Healthcare continues to be transformed by medical advances and technology.
Continuous research and advancements challenge healthcare professionals to keep up
with ongoing changes. Dynamic issues associated with acuity and comorbidities, such as
infection, create unprecedented demands for quality improvements and modifications.
Prior to 2010, researchers found extended antibiotic infusions to be an effective treatment
option with major cost savings (Droege, Van Fleet, & Mueller, 2016; Falagas, Tansarli,
Ikawa, & Vardakas, 2013; Yost & Cappelletty, 2011). As global applications of extended
antibiotic infusions spread rapidly to reduce healthcare costs, researchers realized
significant clinical benefits and positive patient outcomes (Droege et al., 2016; Falagas et
al., 2013; Heinrich et al., 2011; Maddox, DeBoer, & Hammerquist, 2014). Significant
reductions in mortality rates and lengths of stay (LOS) began frequenting the literature as
a direct result of extended antibiotic infusion therapy (Droege et al., 2016; Falagas et al.,
2013; Heinrich et al., 2011; Lee, Liou, Yee, Quan, & Neldner, 2012; Maddox et al., 2014;
Yost & Cappelletty, 2011; Yusuf, Spapen, & Pierard, 2014).
Clinical Scenario
Mr. Johnson was admitted to the hospital for diverticulitis and underwent a
sigmoid colectomy for repair of a micro-perforation of the sigmoid colon. Routine
postoperative management included the administration of an extended antibiotic infusion
of piperacillin/tazobactam (Zosyn®) 3.375 grams intravenously in 50 milliliters (mL) of
normal saline (NS) for a duration of four hours at a frequency of every eight hours. The
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nurse assigned to care for Mr. Johnson on his first postoperative morning entered his
room at 0700 and found his 0400 dose of Zosyn still infusing at the appropriate rate of
12.5 mL hourly. At 0800, the nurse completed the four-hour infusion as indicated on the
electronic medication administration record (MAR), disconnected the tubing from the
patient, and flushed the peripheral intravenous (IV) access with NS in accordance with
protocol. The night nurse documented the administration of the medication at the time
the Zosyn was hung according to the secondary intravenous infusion policy and the day
nurse completed the extended infusion.
This scenario routinely occurs in the selected healthcare organization with
supporting documentation that extended antibiotic infusion administration is flawless.
Further investigation, however, reveals several variables with the potential to
significantly undermine intended patient responses to this pharmacologic therapy.
Variables include:
•

primary and secondary infusion tubing preparation policies,

•

total infusion tubing volumetric capacity (known as dead space; see
Figure 1),

•

primary line NS flush amounts and rates post-infusion to clear the line of
drug,

•

MAR documentation of the infusion start time with an automated stop
time documentation exactly four hours following initiation,

•

individual nursing judgment regarding completion of infusion begun by
the previous nurse.
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This scholarly project identifies the emergence of several clinical issues threatening to
undermine the intended patient responses to extended antibiotic infusion therapy in one
large hospital system.

Secondary
(50 mL)

6 mL
Primary

17 - 22 mL
Patient

Figure 1. Basic Piperacillin/tazobactam Secondary Infusion Setup
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Concepts and Definitions of Terms
Pharmacodynamics of Piperacillin/tazobactam
Piperacillin/tazobactam is a β-Lactam classified antibiotic with time-dependent,
rather than concentration-dependent, pharmacodynamics. Time-dependent antibiotics
have shorter half-lives and can only achieve optimal bacterial killing while being
bacteria-bound for a specific duration of time (Deglin & Vallerand, 2015; Droege et al.,
2016). Peak concentrations of time-dependent antibiotics have limited effect on bacterial
killing. It is the duration of bacterial exposure to the time-dependent antibiotic that
ultimately determines the extent of bacterial destruction. Minimum inhibitory
concentration (MIC) refers to the least amount of antibiotic needed to kill at least 90% of
a bacterial pathogen (Droege et al., 2016; Falagas et al., 2013). An antibiotic’s MIC must
be exceeded for the intended duration to sustain bacterial killing. MICs vary between
40% and 70% of dosing intervals for different antibiotics (Droege et al., 2016).
Physicians ordering a four-hour piperacillin/tazobactam infusion every eight
hours are targeting 50% of the dosing interval to exceed the MIC. Four-hour
piperacillin/tazobactam infusions every eight hours have been found to have the same
clinical benefits for patients as continuous piperacillin/tazobactam infusions (Falagas et
al., 2013). Antibiotic infusions administered too quickly result in shortened durations,
thus minimizing bacterial killing. In addition to achieving optimal bacterial killing, a
pathogen’s MIC has been associated with the potential for inhibiting multi drug-resistant
organisms (MDROs) (Droege et al., 2016; Falagas et al., 2013).
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Stewardship
Extended antibiotic infusion therapy has been studied heavily this century in
response to the escalation of antibiotic resistant bacterial strains and MDROs (Falagas et
al., 2013; Fan et al., 2017). Last year, the Centers for Disease Control and Prevention
(CDC) reported over two million antibiotic resistant cases resulted in approximately
23,000 deaths in the United States (CDC, 2017). MDROs are the result of inconsistent
and ineffective antibiotic usage (CDC, 2017). Antibiotic stewardship refers to the
deliberately organized inter-professional strategies to ensure optimal antibiotic use in
combating infection (American Nurses Association [ANA]/CDC, 2017; CDC, 2017).
Intravascular exposure of the pathogen to the antibiotic for an extended duration is
intended to facilitate extended bacterial killing while suppressing the development of
resistant bacterial mutations. Nurses play an integral role in the stewardship against
MDROs in various healthcare settings (ANA/CDC, 2017; Droege et al, 2016; Manning,
Pfeiffer, & Larson, 2016; Monsees, Goldman, & Popejoy, 2017; Morgan, 2017; Olans,
Olans, & DeMaria, 2016). It is important for nurses to develop and maintain a current
understanding of the pharmacodynamics and pharmacokinetics behind the best practice
evidence supporting extended antibiotic infusions (ANA/CDC, 2017; Droege et al, 2016;
Manning et al., 2016; Monsees et al., 2017; Morgan, 2017). The ANA and CDC
collaborated to emphasize the need for nursing involvement in antibiotic stewardship to
improve antibiotic use in healthcare settings (ANA/CDC, 2017). The CDC (2017)
developed four core actions, including stewardship, to guide professionals in combating
antibiotic resistance. The Joint Commission (2016) established a new standard for
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medication management teams in hospitals as of January 1, 2017, specifically requiring
antimicrobial stewardship action in controlling MDROs.
Dead Space
Dead space refers to the volumetric capacity of the intravenous infusion pathway
a solution travels from exiting its original container until reaching the patient’s
intravascular space (Lam, Bhowmick, Gross, Vanschooneveld, & Weinstein, 2013).
Dead space for the extended antibiotic infusion varies depending on the volumetric
capacities of several infusion pathway setup options. Setups vary according to patient
condition and therapy needs, available supplies, and individual nursing judgment. The
basic setup (see Figure 1) dead space volume ranges from 21 to 28 mL, including
possible extensions and catheters.
The amount of dead space is most significant when the infusion volume is small
(less than 100 mL) and rates are slow (less than 20 mL/hour) (Alexander & Zomp, 2015).
Dead space must be completely displaced by piperacillin/tazobactam before the
medication arrives at the patient’s intravascular space. Without this displacement, the
slow rate of the extended piperacillin/tazobactam infusion (12.5 mL/hour) creates an
infusion delay of approximately two hours. Likewise, when piperacillin/tazobactam
completely exits its original container, the dead space remains filled with the medication.
This dead space must be flushed by the primary solution at the same rate the medication
is ordered because the medication is continuing to infuse (Callahan, 2015).
Backpriming
Backpriming refers to the retrograde filling of the secondary intravenous infusion
pathway with primary solution. The purpose of backpriming is to displace residual
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medication from the previous infusion with primary solution into the used medication bag
which is then discarded. Medications, such as piperacillin/tazobactam, must be stored in
the refrigerator or reconstituted just prior to infusion to maintain optimal
pharmacodynamic effectiveness. Residual medication in the secondary dead space
following an infusion has been at room temperature for several hours and is discarded
through the backpriming process.
Infusion management requires nurses to decide whether or not to backprime prior
to each secondary medication infusion. Backpriming to discard residual medication
versus infusing the residual medication in the secondary infusion pathway is currently left
to nursing judgment. The current nursing practice is generally to backprime for all
secondary medication infusions and dedicate each tubing to its own medication for reuse
for up to four days.
Background
Extended Antibiotic Infusions
The selected practice organization is a large private, nonprofit health care system
in North Carolina that received Magnet recognition by the American Nurses
Credentialing Center in 2015. Extended antibiotic infusions of piperacillin/tazobactam
were added to the pharmacotherapy options at the selected organization in 2010 using
smart pump infusion technology (S. Holt, lead pharmacist overseeing extended antibiotic
infusions in the selected organization, personal communication, September 15, 2017).
Piperacillin/tazobactam infusions formerly administered over 30 minutes at intervals of
six hours began being administered over four hours at intervals of eight hours. The
pharmacy-led implementation in 2010 was primarily introduced as a cost-saving benefit.

8

Both intermittent infusions currently remain in use as pharmacotherapy options in the
selected organization.
Practice Problem
The administration of extended antibiotic infusions in this organization has
encountered two nursing practice problems. These problems were initially identified
through empirical data discovered over an extended period of direct involvement in the
clinical setting. The first issue surrounds the inaccuracies of the nursing administration
process of extended antibiotic infusions. The second issue involves the organizational
system failure to recognize medication administration mishandling with potentially
serious clinical and financial threats.
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SECTION II
Needs Assessment
Organizational Gap Analysis
Best-practice evidence regarding extended antibiotic infusions is relatively recent
in nursing literature and can be associated with a characteristic knowledge to action
healthcare practice gap, as in this selected organization. This nursing practice gap is
characteristic of the assimilation of new evidence and its integration into practice (Field,
Booth, Ilott, & Gerrish, 2014). Based on nursing interviews summarized in Table 1,
patients are currently receiving an uncertain amount of medication at a significantly
reduced duration from that which was ordered.

Table 1.
Causes and Effects of Current Extended Infusion Administration
Administration action
20 – 60 mL flush
amount following
dose

Impact
Flush displacing
residual med in infusion
pathway;

Problem
Risks incomplete
med dose +/or ↓
dose duration

Inaccuracies
Duration and
documentation

12.5 -100 mL/hr
flush rate following
dose

↑rate causes ↓intended
dose duration

Risks ↓ dose
duration;
inconsistency;
uncertainty when
shifts change

Duration and
documentation

Smart pump alarm or
MAR indicator for
infusion completion?

Both indicators variable
based on flush settings;
MAR based on
scanning the container,
not the infusion
beginning at the patient

Inconsistency;
uncertainty when
shifts change;
inaccurate

Dose,
duration, and
documentation
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Following the extended infusion period, flushing procedures used to clear residual
drug volume in the tubing vary among nurses in the selected organization as outlined in
Table 1. According to personal communication, nurses often speed up the volume to
infuse rapidly, which negates the time-dependent pharmacodynamics needed for effective
therapy. Current documentation validates that the nursing administration of extended
antibiotic infusion is consistent and accurate. The assumption throughout the
organization, based on this documentation, is that piperacillin/tazobactam is being
administered consistently and accurately.
As illustrated in Table 1, nurses are administering inconsistent dosage durations.
Nurses are administering inaccurate dosage durations. Nurses are, unintentionally,
documenting inaccurate infusion administration. The “right dose”, “right time”, and
“right documentation” professional standards for nurses are jeopardized by the current
practice. In addition, the practice problem continues to be unrecognized and uncorrected.
Problem Statement
Integration of best-practice pharmacotherapy of extended piperacillin/tazobactam
infusions has evolved inconsistently in the selected organization. The practice problems
in the selected organization are: (1) the inaccurate nursing administration of extended
antibiotic infusions and (2) the organizational system failure to recognize medication
administration mishandling with potentially serious clinical and financial threats.
Scope of the Practice Problem
Current Practice
Extended piperacillin/tazobactam infusions are a frequently utilized
pharmacotherapy at the selected organization for the treatment of both gram positive and
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gram negative infections. Shannon Holt, lead pharmacist overseeing extended antibiotic
infusions in the selected organization, reported piperacillin/tazobactam is the primary
pharmacotherapy for gram negative infection (S. Holt, personal communication,
September 15, 2017). Holt also reported no increases in either gram negative infection
rates or drug-resistant strains since the pharmacy-led implementation of extended
piperacillin/tazobactam infusions in 2010. Since the implementation, however,
significant benefits of mortality and LOS reductions have predominated the literature.
Mortality and LOS have become the primary indicators for extended antibiotic infusion
therapy (Droege et al., 2016; Falagas et al., 2013; Heinrich et al., 2011; Maddox et al.,
2014).
Piperacillin/tazobactam administered in extended dosages in the practice
organization occurred multiple times daily on one clinical unit during direct observation
periods. Associated practice problems can be attributed to knowledge deficits regarding
the time-dependency of piperacillin/tazobactam and infusion dead space volumes.
Nurses administering piperacillin/tazobactam infusions have limited policy guidance to
manage infusion dead space volumes and their effects on infusion durations. Knowledge
deficits and policy confusion regarding infusion volumes have resulted in loss of
approximately 50% of time-dependent infusion therapy with each dose (see Figure 2).
The ANA and CDC White Paper identified antibiotic-related practice problems as a
threat to patient safety (ANA/CDC, 2017).
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Intended infusion administration:
0hr
8hr

2hr

4hr

50% MIC infusion for 4 hours
Piperacillin/tazobactam
50ml at 12.5ml/hr

0hr

2hr

6hr

8hr

No infusion for 4 hours

4hr

6hr

8hr

Duration problem with current infusion administration:
No medication
reaches patient
for approx. 2hrs
but counted as
infusion time due
to current policy

Med reaches patient
and begins infusing
at intended rate

Period left to
nursing judgment
with inconsistent
actions

Figure 2. Eight-hour Medication Frequency Timeline

Clinical Issues
•

Current infusion policy allows varied interpretations of extended infusions.

•

Nurses beginning infusion at the bag rather than the intravascular space due to
dead space volume.

•

Reliance of nurses on smart-pump technology capabilities.

•

Absence of infusion volume capacity on infusion supplies packaging to inform
nurses for decision-making.
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•

EPIC documentation of infusions beginning at false times.

•

Potential variance of actual dosages patients receive with replacement of dead
space volume following infusion.

•

Assumptions of contributors to the infusion process are that nursing management
of infusion volumes is accurate.
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SECTION III
Review of Literature
Best-Practice Evidence
Antibiotic therapy has historically been guided by bacterial susceptibility to a
certain antibiotic. MDROs to the most commonly used antibiotics has resulted in the
emergence of alternative dosing strategies such as the extended antibiotic infusion
(Droege et al., 2016; Falagas et al., 2013). Certain antibiotics, such as
piperacillin/tazobactam, have proven in vitro to be most bactericidal when infused over
an extended period, making them time-dependent antibiotics (Droege et al., 2016;
Falagas et al., 2013; Fan et al., 2017; Lee et al., 2012). Minimal drug concentrations are
needed to inhibit bacterial growth, but concentrations must remain constant for an
extended duration to effectively destroy bacteria. Receiving the entire dose too quickly
interrupts bacterial exposure to the minimal inhibitory concentration (MIC) required to
prevent bacterial growth (Droege et al., 2016; Falagas et al., 2013; Fan et al., 2017).
Therefore, although a bacterial pathogen may be susceptible to an antibiotic and the
entire dose is administered, bacteria are given the opportunity to multiply between
antibiotic doses. In a study of 5,000 patients with hospital associated pneumonia, Kim,
Kuti, and Nicolau (2009) found that three-hour piperacillin/tazobactam infusions were
not as effective as other beta-lactams; but all were more effective than 30-minute
duration infusions. Administering time-dependent antibiotics too quickly has been
associated with longer hospital stays and with greater mortality (Falagas et al., 2013;
Stanford Health Care, 2015).
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In a cohort study of 194 patients with pseudomonas infections, Lodise,
Lomaestro, and Drusano (2007) were the first to associate significant mortality and
length of stay benefits with extended piperacillin/tazobactam infusions. Falagas et al.
(2013) shared a meta-analysis reviewing 14 studies of over 1,200 patients and their
findings relating extended antibiotic infusions to clinical outcomes.
Piperacillin/tazobactam effectiveness was consistently enhanced with extended infusion
durations. Significantly decreased mortality rates and LOS were demonstrated. These
findings continued to be corroborated by multiple researchers as extended infusions were
integrated into global healthcare settings (Lee et al., 2012; Maddox et al., 2014; Schmees
et al., 2016; Yost & Cappelletty, 2011; Yusuf et al., 2014).
Once piperacillin/tazobactam has been ordered as an extended infusion, it is
critical that the infusion time begins when the antibiotic begins infusing into the patient’s
intravascular space. It is just as critical that the infusion continues slowly for the entire
four-hour duration period. (Alexander & Zomp, 2015; Stanford Health Care, 2015).
Alexander and Zomp (2015) reported up to 60% of the piperacillin/tazobactam dose can
be lost to residual dead space volume.
Administration Evidence
A literature review revealed the emergence of both extended antibiotic infusion
therapy and smart pump technology throughout many healthcare settings at
approximately the same time, between 2010 and 2015. Other simultaneous rollouts, such
as electronic patient record (EPR) enhancements, also emerged for many organizations
within the same timeframe, as was the case at the selected organization. Smart pump
usage in United States hospitals has increased from an estimated 44% in 2007 to more
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than70% as of January 2018 (Pedersen & Gumpper, 2008; Institute for Safe Medication
Practices [ISMP], 2018).
Smart pump technology advanced the intravenous infusion capability from
counting drops to pre-programmed infusion libraries with safeguards against much of the
human error associated with medication administration (Ohashi, Dalleur, Dykes, & Bates,
2014; ISMP, 2009; Reston, 2013). Potential solutions to the identified practice problems
must involve implementation and evaluation to optimize the use of best technology
practices. System inefficiencies associated with utilization of new technologies need
quality improvement support that will enhance informatic growth and development
(Ohashi et al., 2014; Trbovich, Cafazzo, & Easty, 2013).
Infusion delivery delay is not widely covered in the literature, but it has been
recognized as a common cognitive task deficiency among nurses (Yui Tsang, 2015). Yui
Tsang (2015), a pharmacist student, developed and implemented an interactive education
simulation for identifying and teaching critical care nurses about infusion volume
management. Heinrich et al. (2011) implemented a hospital-wide extended piperacillintazobactam infusion guideline in total replacement of the 30 minute option in an Illinois
medical center in 2008 with positive results. Researchers felt the single extended
infusion option promoted consistency of administration surrounding the protocol change
and therefore, enhanced reliability of results. Trbovich, Pinkney, Cafazzo, and Easty
(2010) examined nurse utilization of smart pump technology in relation to medication
administration errors. Researcher recommendations cautioned against complacency,
especially with secondary infusions. It was concluded that, although smart pumps
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mitigated many nursing infusion errors, other potential errors regarding pump
programming during each infusion took their place (Trbovich et al., 2010).
Lam et al. (2013) found that as much as 60% of the piperacillin/tazobactam 50
mL dose has been lost to residual tubing volumes. In studies of over 800 nurses, the
ISMP (2018) found the most common type of smart pump errors were associated with
secondary infusions. The reported errors demonstrated nurse confusion about secondary
infusion doses and rates (ISMP, 2018).
Trbovich et al. (2013) evaluated the optimal use of smart pump technology
safeguards in 29 hospitals in Ontario. These researchers identified that underutilization
of potential safety features was common. It was concluded that accuracy of the
medication process required collaborative monitoring of smart pump usage due to
unpredictable and complex implementation variables (Trbovich et al., 2013). Kirkbride
and Vermace (2011) also cautioned nurse managers against the unintentional
consequences of protective technology. Maintenance of an accurate awareness of
administration practices during extended antibiotic infusions throughout the organization
will be key to success.
Extended piperacillin/tazobactam infusions are most commonly selected to target
susceptible pathogens such as fluoroquinolone-resistant Pseudomonas aeruginosa,
Klebsiella pneumoniae, Escherichia coli, or carbapenem-resistant Enterobacteriaceae
(CRE) (Droege et al., 2016). Extended piperacillin-tazobactam infusions have yielded
benefits of significantly reduced lengths of hospital stays and mortality rates for patients
(Buyle et al., 2013; Heinrich et al., 2011; Falagas et al., 2013; Lee et al., 2012; Lodise et
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al., 2007; Maddox et al., 2014; Schmees et al., 2016; Yost & Cappelletti, 2011; Yusuf et
al., 2014).
Literature Summary
A Literature Review Matrix outlines major details (see Appendix A). Overall, the
evolution of evidence surrounding extended antibiotic infusion therapy demonstrates a
transition from economical healthcare infusion benefits to clinical outcome benefits for
patients experiencing infections. Cost benefit, the original incentive for extended
infusion therapy, is now secondary to significant mortality and length of stay reductions.
Consistently competent administration of extended antibiotic infusions is
fundamental to the achievement of successful patient outcomes the literature
demonstrates. Direct observation and personal communication with frontline nursing
staff and policy-makers corroborate knowledge deficits regarding best-practice
pharmacotherapy. Compliance with best-practice evidence is critical to the achievement
of similar clinical benefits for patients. Unaddressed infusion errors during timedependent infusion therapy directly impact the success of clinical patient outcomes.
Current extended infusion issues at the selected organization warrant further investigation
with translation and application of best-practice solutions.
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SECTION IV
Theoretical Framework
Swanson’s Theory of Caring
Kristen Swanson’s (1993) Theory of Caring provides the theoretical framework
for this practice project to enhance extended antibiotic infusion administration accuracy
and efficient dose delivery for clients experiencing infections. “Nursing is informed
caring for the well-being of others” (Swanson, 1993, p. 352). Swanson’s (1993)
explanatory middle-range nursing theory defines “others” as individuals or groups, or
issues that jeopardize well-being. The theory of caring outlines specific caring processes
within the context of four phenomena common to nursing practice: persons or clients,
health and well-being, environments, and nursing (Swanson, 1993). These phenomena
are common to nursing practice, but not exclusive to nursing practice (Swanson, 1993).
The unaddressed infusion issues during administration of extended antibiotic therapy in
the selected organization constitute a nursing practice issue that influences client wellbeing.
The five caring processes are hierarchically structured beginning with
“maintaining belief”, the foundational values and beliefs guiding nurses to assist others
through their specific situations (Swanson, 1993). This basic underlying foundation of
beliefs inherent to nursing, through the actions of each nurse, initiates the relationship
between the nurse and others toward some future outcome (Swanson, 1993). Nurses
accompany others through their experiences or situations to provide therapeutic
assistance (Swanson, 1991). The theory of caring identifies clinical nursing knowledge
as the second caring process toward achieving planned outcomes (Swanson, 1993). What
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nurses know and understand regarding specific client data determines the care that nurses
will tailor to be most therapeutic (Field et al., 2014; Swanson, 1993). Holistic awareness
and understanding of individual patient influences and needs guide nursing judgment and
caring actions. Swanson further elaborates that knowing promotes scholarly nursing
practice applications and translations (Swanson, 1993).
The remaining three caring processes, “being with, doing for, and enabling”
(Swanson, 1993, p. 355), directly support the effectiveness of nursing care in promoting
client well-being. Responsibility and accountability of nurses to others, including
oneself, impacts individual perceptions of dignity and worth (Swanson, 1991; Swanson,
1993). Recipients of nursing care based on caring theory perceive protection and security
from competent nursing skillsets (Swanson, 1991; Swanson, 1993). Recipients of
nursing care (whether clients, issues, or nurses themselves) progress through personal
experiences toward an intended result (Swanson, 1993).
Swanson’s structured caring processes serve as the ideal organizational
framework for planning and implementing a policy revision and quality improvement
initiative to achieve optimal pharmacotherapy for clients (see Figure 3). The theory of
caring provides praxis to guide all nursing relationships; those with clients, other nurses,
other disciplines, and with oneself (Butts & Rich, 2015; Swanson, 1993). Because these
dynamic inter-relationships continuously influence the implementation process, they
require ongoing assessment and management (Field et al., 2014). Sustainable knowledge
translation can be expected to withstand barriers to the change process through the use of
implementation science strategies (Field et al., 2014). Implementing change within an
organization can be mindfully facilitated through the use of Swanson’s Theory of Caring
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to translate knowledge of best-practice among nurses with the intention of enhancing
client well-being (Swanson, 1993).

Maintaining Belief

Knowing

•

Being with

•

Doing for

•

Enabling

Self-instruction

Redefinition of

Consistent and

Completion by

the Beginning

Competent

Unit Nursing

of the Infusion

Infusion

Staff

Therapy

Therapy

Post-Implementation Summative
Evaluation and Qualitative Survey

Figure 3. Conceptual/Theoretical/Empirical (CTE) Diagram Based on Swanson’s
Theory of Caring
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SECTION V
Project Mission, Goals, and Objectives
Mission Statement
The purpose of this scholarly project was to improve extended antibiotic
infusion administration of piperacillin/tazobactam therapy by teaching best practice
strategies for consistent and compliant dose delivery needed by patients experiencing
infections.
Goals
The anticipated goals for this scholarly project are:
•

Recognition and application of best-practice pharmacotherapy guiding
extended antibiotic infusion administration

•

Recommendations for a system-wide self-instruction module for nurses

•

Recommendations for a revision to the extended infusion administration
policy.
Objectives

The objectives of this scholarly project are:
•

Attestation to completion of a self-instruction module redefining extended
antibiotic infusion administration by 100% of unit nurses

•

Summative validation of understanding regarding the nursing administration
of time-dependent antibiotics by 100% of unit nurses upon completion of the
self-instruction module
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•

Self-reported increase in understanding of the nursing administration of timedependent antibiotics by 100% of responding unit nurses upon completion of
the self-instruction module

•

Consistent and accurate delivery of four-hour intravascular antibiotic exposure
by 100% of unit nurses upon completion of the self-instruction module as
randomly monitored for two weeks.
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SECTION VI
Project Design
Site and Population
The selected unit for implementation of this pilot project was a 41-bed
cardiovascular surgical intermediate care unit with approximately 80 staff nurses.
Employment on the unit ranges from one to 35 years. The majority of nurses have a
Bachelor of Science in Nursing (BSN) level of education and many have achieved
national medical-surgical certifications.

Table 2
Project Team Members
Team Members
Kelly Thompson-Brazill

Reasons for Selection
Selected Practice Partner; DNP with respected clinical
expertise and organizational network

Megan Swink, Morning
unit supervisor and
tenured staff nurse

Selected Committee Member; knowledgeable of frontline
staff practices on direct observation unit; respected,
energetic, and proactive with clinical expertise and
organizational network

Sandra VanScoy, Nurse
manager and tenure on
observation unit

Thirty-two years of tenure on direct observation unit;
respected for availability, support, and expertise

Shannon Holt, Pharmacist

Responsible for management of antibiotic dosing in
collaboration with Dr. Ingram, Infectious Disease
Specialist; aggregates all data regarding extended
antibiotic infusions

Dr. Chris Ingram

Infectious Disease Specialist

Dr. Eric Raasch

Pharmacy and Therapeutics Committee (P&T)
Systemwide Chair
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Facilitators
The selected organization consistently demonstrates numerous strengths,
especially after receiving Magnet Recognition status. An organizational culture of
striving for excellence in maintaining competitive quality health care outcomes for
patients throughout the region is communicated within the hospital system as well as
through community outreach and support. Organizational growth and development
demonstrate the successful mission of improving health care provision through quality
and compassion. Patients and families are positioned at the top of the hierarchal pyramid.
Specific achievements validating this structure are displayed on each unit. Employees
actively participate in decision-making through shared governance and committee
integration of quality improvements.
Barriers
Three identified barriers to integration of best infusion practices contribute to the
inaccurate administration of piperacillin/tazobactam extended infusions in the selected
organization. The first barrier to overcome in implementing a solution is the knowledge
deficit of the nursing staff associated with dead space volumes as well as the timedependency dynamic of piperacillin/tazobactam. Training regarding extended antibiotic
therapy was provided to nurses at the selected organization in 2010, but frontline staff
nurses were taught there were no advantages to extended infusions beyond cost savings.
Subsequent evidence discovered since then identified cost savings is a secondary benefit
of the extended piperacillin/tazobactam infusions (Heinrich et al., 2011; Maddox et al.,
2014; Droege et al., 2016). The primary advantage to extended therapy has become its
clinical benefit to patients; that evidence is currently translating to the selected

26

organization and nursing practice (Buyle et al., 2013; Falagas et al., 2013; Yusuf et al.,
2014). Education regarding time-dependency in antibiotic administration to nurses at the
selected organization is critical to the implementation of accurate extended antibiotic
infusions. Heinrich et al. (2011) demonstrated successful implementation of new
guidelines in a structured educational training session for all involved professionals in a
500-bed Chicago hospital.
A second barrier to accurate extended antibiotic infusions is the absence of tubing
volume capacity information for use by the frontline nursing staff when programming the
infusions. Knowledge of the volume capacity of the infusion tubing is essential to
accurately determining infusion beginning and end points (Alexander & Zomp, 2015;
Lam et al., 2013). Failure to include this volume in the current infusion setup has
resulted in a significant delivery delay in the selected organization. With current nursing
practice, the antibiotic does not reach the patient until the third hour of the intended fourhour infusion.
The project manager discovered a third barrier to correcting the practice problem,
more fragmentation throughout this organization than originally recognized. The
selected organization is large and the dynamics of problem-solving are complicated by
the ongoing daily challenges and complexities of managing multiple campuses.
Communication is unexpectedly difficult given the quantity of responsible stakeholders
and the magnitude of the practice problem. The magnitude of this practice problem adds
an overwhelming element for stakeholders anticipating an equally complex solution. The
planning period needed to develop the redefinition pilot project was extended by the
fragmentation encountered. Going forward through the implementation and reporting of
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results phases, this project manager more effectively managed the intra-organizational
division of responsibilities to streamline efforts and outputs.
SWOT Analysis
Strengths, weaknesses, opportunities, and threats (SWOT) analysis of the
practices, policies, and opportunities in the selected organization revealed a gap between
actual and intended practice procedures as illustrated in Table 3. Internal and external
strengths of the selected organization clearly exceed the internal and external weaknesses
(see Table 3). The foundational climate of the selected organization is perceived as
professional and valuing quality care both internally and throughout the community.
Acknowledgement of the practice problem with various stakeholders has elicited
concerned responses and participatory implementation toward a policy update as well as
a quality improvement initiative.
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Table 3
SWOT Analysis

Internal

External

Positive
• Culture of striving for
excellence in maintaining
competitive quality health care
outcomes for patients
throughout the region
• Patients and families are
positioned at the top of the
hierarchal pyramid
• Specific achievements
validating this structure are
displayed on each unit
• Employees involved in
decision-making through shared
governance and committee
integration of quality
improvements
• Well-educated and skilled
frontline nursing staff
• Collaboration between
pharmacy and physician
professionals with nurses
mutually respected throughout
this organizational system
culture
• Adequate physical and fiscal
resources

Negative
• Miscommunication of
information in rollout
• Absence of tubing volume
capacity information for use by
the frontline nursing staff when
programming the infusions
• Policy for secondary intravenous
infusions allows variability in the
administration
• Ineffective ongoing monitoring of
extended infusions
• Persistent nosocomial pathogens

• Community outreach and
support
• Organizational system growth
and development
• Respected reputation nationally
• Magnet recognition
• Successful mission of
improving health care provision
through quality and compassion

• Increasing multi-drug resistant
pathogens with decreasing
antibiotic choices
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Implementation Plan/Procedures
The educational intervention translated best practice evidence for the nursing staff
on the pilot unit to relocate the intended beginning point of extended
piperacillin/tazobactam infusions. Clarification of the time-dependent
pharmacodynamics emphasized the importance of beginning the infusion as the
medication enters the patient’s bloodstream, instead of the medication’s exit from the
medication container. Nurses were instructed to follow a recommended administration
process similar to the current practice with one major addition, a 25 mL manual
secondary bolus using the smart pump to displace the dead space volume in the infusion
tubing currently creating the infusion delay. This process clears the secondary and
primary dead space volume of saline between the medication container and the patient’s
bloodstream; thus, relocating the beginning of the infusion to the patient’s bloodstream as
the physician orders intended. This process is compatible with either continuous
infusions of intravenous fluids or saline locked devices.
Intervention and Measurements
A self-instruction module (see Appendix B) and demonstration video was emailed
to each full- and part-time unit staff nurse (80 total nurses) by their unit management
team. Completion of the self-instruction module was mandated within a two-week
period. A post-instructional summative evaluation of five multiple choice questions
(included in Appendix B) and a signed attestation of understanding of the information
presented (included in Appendix B) was submitted to the unit supervisor by the end of
the two-week self-instruction period. The project manager scored all summative
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evaluations and analyzed data using descriptive statistics. Evaluation results were
confidential.
Post-instructional application of information was randomly observed and
evaluated by the project manager for consistency and accuracy for a four-week period
using a checklist based on the new extended antibiotic infusion policy. An average of
25% of patients on the 41-bed unit were receiving this extended infusion and 11 nurses
were staffing each day. Both day and night shift nurses monitored between 0600 and
1500 until at least half of the unit nurses were assessed for compliance with the new
procedure. Monitoring included direct observation and personal staff interviews. The
nursing administration of infusions was randomly observed in patient rooms during the
monitoring phase without any recording of patient or nurse information whatsoever. For
each randomly selected infusion, information about how the nurse was administering the
medication was easily reviewed using the pump keypad to establish whether the
instruction module was understood and followed. This was an additional opportunity for
individual remediation to be offered by the project manager as needed. The only nurse
information needed during the monitoring phase was to check off nurses’ names that
were observed, so they were only observed once.
The final outcome measure was a staff survey (see Appendix C) about the
instruction module and staff nurse perceptions of the redefinition application. An online
Survey Monkey link was emailed to all nurses with an explanation and instructions (see
Appendix C). The project manager analyzed data using descriptive statistics and collated
answers to the last two questions regarding concerns and feedback.
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An overall summary of results was to be shared with associated physician,
nursing, and pharmacy representatives throughout the project site via personal
communication, PowerPoint presentation, or email. Ultimately, pilot project results
were to be presented to the Nursing Practice Council, during the May 2018 meeting,
with recommendations to facilitate system-wide practice improvements.
Cost Analysis/Budget
Multiple researchers have reported reductions in mortality and LOS with the
implementation of extended antibiotic infusions (Heinrich et al., 2011; Falagas et al.,
2013; Maddox et al., 2014; Yusuf et al., 2014). Extended infusions have been widely
documented as beneficial due to enhanced exposure of bacteria to antibiotic therapy with
a cost-effective bonus of using less medication (Droege et al., 2016). Fiscal and physical
resources necessary for this practice implementation project would be limited to time
expenditures; equipment and supplies are already present due to current infusion
practices. Time would be needed for a system needs assessment, data analysis of current
practices, education of nurses about best infusion evidence, policy development and
implementation, evaluation of updated practice application through direct observation,
and quality improvement process enhancement to sustain quality practice and optimal
care outcomes. Costs associated with LOS, clinical outcomes, and mortality are
considerable, multifaceted, and remain beyond the scope of this practice improvement
initiative.
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Table 4
Project Timeline
Project Timeline
Summer 2017
Problem Recognition
Preliminary Literature Review of Problem
Needs Assessment
Expanded Literature Review for Best Practice
Organizational Assessment
Development of Goals and Outcome Objectives
Development of Mission Statement

June 2017
July 2017
July 2017
July 2017
July 2017
August 2017
August 2017

Fall 2017
Complete CITI Research Training
Theoretical Underpinnings
Work Planning
Evaluation Planning
Continuing Practice Immersion Experience
Register for Spring 2018
Complete and Submit Project Proposal

September 2017
September 2017
October 2017
November 2017
November 2017
December 2017
December 2017

Spring 2018
Apply for GWU Summer Graduation
Application for Hospital IRB Exempt Status
Application for GWU IRB Exempt Status
Implementation
Implementation Monitoring
Data Analysis and Aggregation
Implementation and Practice Immersion Closure
Recommendations to Nursing Practice Council
Evaluation

January 2018
January 2018
January 2018
February 2018
March 2018
April 2018
May 2018
May 2018
May 2018

Summer 2018
Written Dissemination/
Oral Dissemination
Electronic Dissemination/Manuscript Preparation
ProQuest Submission
Graduation

June 2018
July 2018
July 2018
July 2018
August 2018
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SECTION VII
Implementation
Methodology
This quality improvement project piloted an educational initiative to inform
nursing staff on one nursing unit of best practice evidence affecting extended antibiotic
infusion management. Two project initiatives were implemented:
(1) Nursing Educational Initiative
•

Self-instruction module (see Appendix B) translated evidence about time
dependent antibiotic infusions for improved administration

•

Demonstration video link supported the self-instruction process

•

Post-instructional summative evaluation (five questions) determined
understanding of new information

•

Post-instructional staff survey (see Appendix C) evaluated resulting
consistency and competency with extended infusion management

•

Post-instructional application randomly monitored by direct observation of
administration and personal staff interviews during scheduled
piperacillin/tazobactam therapy

(2) Inter-professional Awareness
Pilot project results were shared with pharmacist Shannon Holt, Pharmacy and
Therapeutics Committee (P&T) Systemwide Chair, Dr. Eric Raasch, and Infectious
Disease Specialist, Dr. Chis Ingram. Pilot project results were presented to the Nursing
Practice Council by May 2018 with recommendations for system-wide use.
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Demographics
Seventy-three nurses employed on one unit in the selected organization during the
pilot project period were mandated by their management team to participate in this
quality improvement pilot project. Pertinent participant demographics regarding nursing
experience and nursing education, described in Table 5, demonstrate the majority of
nursing staff on the pilot unit is both highly experienced and well-educated.
Table 5
Experience and Education of Unit Staff Nurses
Experience and Education of Unit Staff Nurses

Experience

Nurses

0 – 3 years

22 (30%)

3 – 5 years

3 (4%)

5-10 years

15 (21%)

>10 years

33 (45%)

Education

Nurses

ADN

20 (27%)

BSN

52 (71%)

MSN

1 (1%)

National Medical-Surgical Certification

23 (32%)
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Intervention
Implementation of the educational intervention was accomplished using an
electronic self-instructional strategy. This pilot was intended to determine the
effectiveness of the self-instruction strategy in the quality improvement of the
administration of this extended infusion. The electronic self-instructional process could
be easily replicated system-wide following this pilot project. The self-instruction module
(see Appendix B) was emailed to each full- and part-time unit staff nurse (73 total nurses)
by their unit management team. The management team decided to mandate the selfinstruction in the interest of quality improvement. Attestations for staff nurses to submit
by a certain date were included in the email, however no penalty was communicated or
planned. Completion of the self-instruction module was mandated within the two-week
period in March of 2018. No additional instruction was provided to the staff nurses
regarding the new extended antibiotic infusion procedure. A post-instructional
summative evaluation of five multiple choice questions and a signed attestation of
understanding of the information presented were included in the self-instruction to be
submitted to the unit supervisor by the end of the two-week self-instruction period. The
project manager scored all summative evaluations to maintain participant confidentiality.
Post-instructional application of information was randomly observed and
evaluated by the project manager for consistency and accuracy for a three-week period.
A checklist based on the new extended antibiotic infusion process was used throughout
the monitoring period. The project manager monitored the process application by direct
observation and personal staff interviews regarding variables affecting the duration of the
infusion. The nursing administration of infusions was randomly observed in patient
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rooms during the monitoring phase without any recording of patient information.
Information regarding instruction and instruction application obtained during staff nurse
interviews was recorded without any specific nurse identifiers. Information was observed
on the smart pump during administration or communicated by the nurse regarding each
randomly selected infusion to establish whether the instruction was followed. For each
randomly selected infusion, information about how the nurse administered the medication
was easily reviewed using the pump keypad to establish whether the new procedure
instructions were followed.
An anonymous staff survey (see Appendix C) was encouraged to be completed as
an outcome measure of this pilot project. If staff nurses opted not to complete the
voluntary survey, they were advised to delete it without penalty. An explanation and
instructions for the staff survey were emailed by the unit management team to all unit
nurses with a Survey Monkey link. This email was resent to all unit nurses two weeks
later.
An overall summary of results was presented to the Nursing Practice Council with
recommendations for a policy update to correct infusion infractions system-wide. Results
were also shared with physician and pharmacy representatives.
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SECTION VIII
Findings
The goal of this project was to evaluate the effectiveness of a self-instruction
module in improving the quality of the extended antibiotic infusion process. Intended
outcomes were to observe consistent and competent application of best practice evidence
following self-instruction on one nursing unit during random infusion monitoring. This
was measured after the instruction period by direct observation of smart pump dose
delivery settings associated with administration of random extended antibiotic infusions.
These findings were dependent upon the self-instruction module completion by staff
nurses and their understanding of the best-practice evidence provided. Staff nurse
understanding was validated using two methods, a summative multiple- choice
assessment and a self-reporting survey.
Instruction Effectiveness
First, the effectiveness of the self-instruction module was evaluated immediately
upon completion by each staff nurse using a five-item multiple-choice summative posttest assessment. Of the 73 nurses who were emailed a self-instruction module, a total of
30 (41%) nurses submitted an attestation for completing the instruction. Each nurse
completing the instruction responded 100% correctly to all five post-test questions (150
questions/150 correct).
Second, the self-instruction effectiveness was evaluated several weeks following
completion using an anonymous staff survey (see Appendix C). All 73 staff nurses were
emailed a Survey Monkey link to self-report responses indicating personal reflections
about understanding of the instruction and practice application of the instruction. Of the
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30 nurses completing the instruction, nine nurses (30%) responded to the staff survey.
All respondents either agreed (38%) or strongly agreed (62%) with every item. Three
respondents reported having administered the infusion using the new process. No
problems were encountered. (Table 6 & 7).

Table 6
Staff Survey Ratings
Staff Survey Ratings
Agree

Strongly Agree

1. Instructions easy to understand (knowledge)

5

4

2. Completion time reasonable (skill)

5

4

3. Infusion management awareness improved (knowledge)

4

5

4. Time dependent antibiotic awareness improved (knowledge)

3

6

5. Comfortable implementing new process (skill)

3

6

6. Quality improvement for patients (attitude)

2

7

7. Quality improvement for nursing practice (attitude)

2

7

Table 7
Collation of Staff Survey Comments
Collation of Staff Survey Comments
Total
Clear and easy to understand

3

New information

1

Shocked to realize infractions

1
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Instruction Application
Following the instructional intervention to improve staff nurse understanding of
time dependent antibiotic administration, evaluation of consistent and competent
application of the learning was measured. Over a period of three weeks post-instruction,
29 infusions were randomly selected for direct observation (see Appendix D). All shifts
were monitored. Six days of the week were monitored (excluding Sunday). Of the
randomly observed post-instruction infusions, 17 of 29 pumps (59%) were programmed
to infuse according to the instruction. This was evidenced by observation of the
secondary volume to be infused (VTBI) programmed at 25 mL indicating the dead space
volume had been deliberately adjusted by the nurse after the priming bolus. In three of
those observations, the VTBI remained at 50 mL, so the nurse was interviewed for
affirmation the priming bolus had been performed. In addition to observation and/or
interview, a primary fluid flush rate of 12.5 mL indicated the nurse had completed the
instruction and accurately applied the new infusion procedure (see Figure 4).
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Frequency of Primary Flush Rates
After Instruction (N=29)
17
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Frequency
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Figure 4. Frequency of Primary Flush Rates after Instruction

Measurement of Pre and Post Instruction Durations
The intended duration of the extended antibiotic infusion is four hours (240
minutes). Prior to instruction, durations ranged from 132 minutes to 144 minutes. This
means that durations of the infusions ranged from 55% to 60% of the duration that was
ordered to be administered. No infusions were found to be accurately delivering the fourhour duration as ordered.
Shortest durations:
The shortest infusions flushed for 12 minutes (20 mL at 100 mL/hr).
Longest durations:
The longest infusions flushed for 24 minutes (20 mL at 50 mL/hr).
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Following the instruction period, 17 extended infusions were observed being
administered according to the instruction. These infusion durations were 240 minutes or
100% the four-hour duration as ordered. Therefore, post-instruction, 100% of infusions
were found to be accurately delivering the therapeutic four-hour duration. The remaining
monitored infusions varied in shortened duration ranges consistent with pre-instruction
findings.
Measurement of Pre and Post Instruction MIC
The intended infusion duration for piperacillin/tazobactam is T > 50% at MIC, or
50% of the eight hour dosing interval at the minimum inhibitory concentration. Prior to
instruction, the shortest infusions flushed for 12 minutes (20 mL at 100 mL/hr) or 28% at
MIC. The longest infusions flushed for 24 minutes (20 mL at 50 mL/hr) or 30% at MIC.
The average of these, 29% at MIC, represents an overall shortened and sub-therapeutic
pre-instruction infusion process. In comparison, the post-instruction 50% at MIC
represents a therapeutic infusion duration in 100% of observations. (Figure 5).
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Pre- & Post-Instruction Comparison
% Duration at MIC
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Figure 5. Pre and Post Instruction Comparison

Post-Instruction
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SECTION IX
Interpretation of Findings
Instruction Effectiveness Evaluation
Interpretation of project findings substantiates the overall effectiveness of the selfinstruction module in improving extended antibiotic infusions. Based on post-test results
immediately following instruction and staff surveys weeks later, nurses associated the
instruction with individual understanding of the new information. One hundred percent
of 150 post-test questions were answered correctly by nurses upon completing the
instruction. In addition, nurses responding positively to the staff survey several weeks
following instruction indicates retention of the new information.
A staff survey response of 30% represents a typical and acceptable rate. Survey
items investigated individual nursing knowledge (items 1,3, and 4), skill (items 2 and 5),
and attitude (items 6 and 7) of the respondents about the instruction. Respondents
unanimously indicated positive opinions toward the self-instruction and its application to
their practice. Likert ratings for the first seven survey items vary slightly. More
respondents agreed with items associated with ease and effort (2 of 7) than strongly
agreed. More respondents strongly agreed with remaining items (5 of 7) than agreed.
This suggests consideration and evaluation on the part of the respondents prior to
selecting their responses. Respondents consistently value the overall instruction and feel
confident to apply their new learning to patient care. In addition, respondents
unanimously recognize system-wide benefit to the instruction.
Collation of survey comments also supported the positive overall response to the
self-instruction module. The lengthiest comment communicated shock at the realization
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of the infusion infractions. One nurse’s expression of concern over tiny bubbles resulting
from the priming bolus speed is worth noting. This nurse preferred to prime the tubing at
a rate of 400mL/hour and clamp the primary tubing with an instrument clamp for the four
minutes the prime takes at that rate. This is an individual nurse preference that in no way
alters the infusion duration from the new procedure.
Instruction Limitations
Two limitations were identified during the implementation of this pilot project
that had a significant effect on the instruction. Both limitations were related to the
accessibility of the instruction module for completion by the unit nurses. The first
limitation was the ineffective email delivery to the nurses. Emails delivered to the nurses
were not necessarily visible to the nurses. The email issue was discovered when the
instruction period concluded with only 16 of 73 attestations for completing the mandated
instruction. Further investigation revealed the enormous quantity of emails received
daily by each nurse. The overwhelming quantity resulted in the habitual neglect of
nurses to check their email. Hypothetically, if a nurse failed to check email for two days,
that nurse would likely never see a mandated item. In this case, the nurses were
anticipating the mandated instruction introduced by their management team, yet the
majority of nurses never realized it had arrived. The instruction period was extended for
an additional two weeks to allow more nurses an opportunity for completion.
As the monitoring phase began, it became clear that many nurses had still not
seen the instruction module. During this time, a second limitation was identified. Float
pool nurses were regularly assigned to the pilot unit throughout the pilot project period.
Float pool nurses were not included in the instruction module delivery email and,
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therefore, could not complete the instruction. Notations were made when a float pool
nurse was identified as administering the infusion during the monitoring period. Though
these limitations were identified, they had no direct bearing on the overall results, as only
the data from nurses who had completed the instruction were examined, collated, and
considered.
Instruction effectiveness findings validate the achievement of instruction
understanding by the nurses who attested to completing the self-instruction module. This
is evidenced by perfect post-test scores as well as individual nurse reporting in survey
responses. The instruction application evaluation demonstrates the post instruction
consistency and competency of nurses during random infusion monitoring.
Instruction Application Evaluation
Direct observation of 29 randomly selected infusions validated consistent and
competent application of the new extended infusion procedure by staff nurses post
instruction. This was evidenced by 100% of nurses demonstrating capability and
accuracy in using the new procedure throughout the three-week post instruction
monitoring period. In addition, despite limitations in accessibility of the self-instruction,
infusions programmed for 100% of the duration ordered increased by 72% post
instruction.
The duration problem created by the DSV is two-fold on both the front and back
ends of the extended infusion. Nurses must demonstrate that the infusion is primed to the
patient’s infusion site before beginning the infusion. Nurses must also demonstrate that
the infusion is flushed at the same rate of the infusion while residual dead space volume
containing medication continues to infuse. Monitoring strategies validate which nurses
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primed and flushed accurately using the new procedure. Since no nurses were found to
prime or flush infusions accurately pre-instruction and the procedure in the instruction is
new to the nurses, accurate use of the new procedure post-instruction indicates
completion of the instruction. Therefore, of the nurses indicating completion of the selfinstruction with accurate programming of their smart pump, 100% demonstrate consistent
and competent application of instruction.
A comparison of pre and post instruction durations also substantiates the
consistent and competent application of instruction by the nursing staff. Seventeen
infusions observed delivering the complete four-hour duration post instruction quantifies
the effectiveness of the self-instruction. In terms of the MIC required for effective
therapeutic patient benefit, findings are consistent. The average range of infusion
duration pre-instruction translates to an average of 29% at MIC, which is significantly
sub-therapeutic. The post-instruction duration of 50% at MIC represents delivery of the
complete duration of medication as ordered in 100% of observations. The difference in
duration time at MIC pre and post instruction demonstrates an improvement of 72% in
the therapeutic duration delivery of piperacillin/tazobactam (50-29 = 21; 21/29 = 72%
duration improvement).
Comparison to Literature
Nursing-led implementations such as this pilot project were not encountered in
the literature. Infusion-associated implementations are most often pharmacy-led efforts
due to the pharmacological impacts involved. Inter-professional collaboratives
surrounding infusion administration should optimally include nursing input. The
literature continues to reveal an ongoing gap in nursing infusion management cognition.
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Gaps also continue to surround the recognition of beneficial support opportunities
involving smart pump safeguards and capabilities.
A sustainable system-wide implementation to improve extended antibiotic
infusions will require an ongoing awareness of and sensitivity to variations among
individuals and groups involved with the change. It is important to involve persons who
are considering a practice change in identifying the problems as well as determining an
action plan. The change process will be a deliberate buy-in choice for each staff member.
Porter-O’Grady and Malloch (2015) warned that variables including readiness for change
and subtle group dynamics could influence stakeholders throughout the change process
and should be closely monitored. The Society of Critical Care Medicine (2017)
recognized two helpful strategies when implementing a practice initiative. One
recommended strategy was to minimize the number of steps associated with the change.
The second strategy was to maintain consistency among the steps whenever possible to
minimize the risk of confusion or misinterpretation. These strategies were respected
during the development of the new infusion procedure included in this pilot project.
Comparison to Swanson’s Theory of Caring
Kristen Swanson clearly outlined the ideal framework supporting this pilot project
to improve extended antibiotic infusions. Inaccurate delivery of infusion therapy is a
nursing practice issue that impacts client well-being, one of the four phenomena she
identified as common to nursing practice. The five caring processes direct nurses toward
a therapeutic outcome that recognized nursing knowledge as integral to tailoring
individual patient care. Being with, doing for, and enabling, the final three caring
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processes, sustain the nursing responsibility for optimizing an infusion process that
patients perceive to be ideal in meeting their therapeutic needs.

Recommendations
As a result of this scholarly pilot project, several recommendations associated
with the practice problem and proposed solution are indicated. Findings validate the
effectiveness of the self-instruction module in improving the delivery of extended
antibiotic infusions. Nurses are consistently and competently applying the new infusion
procedure to their practice following completion of the self-instruction module. First,
system-wide instruction should be mandated to improve the extended antibiotic infusion
process to that which is ordered, expected, and therapeutic for patients. Next, strategies
other than a single email must be used to make the instruction accessible to all nurses.
Third, a demonstration video provided with the self-instruction module was never
mentioned by any of the nurses. Instruction on a larger scale would be best supported by
a video with enhanced visibility so that visual learners could benefit by being able to read
the smart pump settings.
A few minor alterations were made to the new infusion procedure following staff
surveys, direct observation, and interviews of the nurses. A majority of survey
respondents felt least agreeable with ease and effort items, so adjustments were made to
shorten the overall written procedure. These alterations were included in the procedure
presented to the Nursing Practice Council. No backpriming is needed prior to priming
the infusion tubing with medication. This is, however, a difference in procedure from
administering any other secondary infusion and it would not affect the new procedure if
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the nurse preferred to continue the routine. Backpriming is still a requirement when
changing the secondary tubing. The VTBI was altered to match the secondary and
primary programming. With this alteration, the nurse would more easily program both
the secondary and primary bags with the same rates and VTBI. The option to slow the
priming bolus rate was added along with the rationale that it lengthens the priming time.
Some nurses prefer to slow the priming bolus; this does not affect the infusion duration.
The option for nurses to clamp or pinch primary tubing during the priming bolus also has
no effect on the infusion duration. Disconnection of the infusion tubing between
infusions was also recommended for enhanced patient mobility.
Conclusion
The solution to the practice problem including a new infusion procedure was
piloted on one unit and evaluated for efficacy. Results and recommendations regarding
system-wide implementation were presented to the Nursing Practice Council in May of
2018 and are currently being considered. The proposed medication bolus into the tubing
serves to redefine the beginning of the extended antibiotic infusion to that which was
ordered for the duration which was ordered. The intended beginning of an antibiotic
infusion is the patient’s intravascular space, not the infusion tubing. This redefinition
should be recognized by nurses system-wide for the accurate administration and
consistent delivery of time dependent medications over the duration periods ordered by
physicians.
Documentation appeared that infusions were administered correctly over four
hours as ordered, but direct observation at bedsides revealed that was not true. Direct
observation of the post-instruction application by staff nurses revealed a 72%
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improvement in duration delivery despite significant issues regarding accessibility of the
instruction.
This scholarly practice project is intended to culminate in a system-wide
awareness of a significant practice problem with direct impact on the success of clinical
patient outcomes. Although assessment of clinical outcomes would exceed the scope of
this project, the educational intervention pilot to redefine the appropriate beginning of the
extended antibiotic infusion is a sustainable solution to this practice problem. The quality
improvement of extended infusions on the pilot unit following self-instruction is
significant. Recommendations resulting from this redefinition pilot project are intended
to facilitate a system-wide extended infusion policy update to improve the delivery of
extended antibiotic infusion durations for patients experiencing infections.
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Best practices: Full-dose
delivery of intravenous
medications via infusion
pumps.

Title

Critical Care Nurse
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infusion tubing volumes and
residual IVPB overfill and
examines dose precision and
potential clinical significance

Doses delivered using only
primary tubing less suitable for
smaller total dose volumes due to
significant dose residual in
tubing.
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the dose can be lost to residual
tubing volume post infusion.
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dilemmas of infusion line dead
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deadspace as with primary tubing
risks infusion of degraded drug
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pharmacodynamics and dosing
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antibiotic pharmacotherapy in
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patient outcomes.

Researchers update nurses about
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the clinical effectiveness.
Carbapenems = 40% MIC and
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Fan, S., Shum, H.,
Cheng, W., Chan,
Y., Leung, S. M., &
Yan, W

Clinical outcomes of extended
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The Journal of
Human
Pharmacology and
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Therapeutics
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Smart pumps: Implications for
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Outcomes of extendedinfusion piperacillintazobactam: A retrospective
analysis of critically ill
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Therapeutics
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effectiveness

Retrospective pre and post
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Cohort study of 194 patients
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medication error rates: a
systematic review.
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monte carlo simulation and
steady-state pharmacokinetic
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Valenti, K.
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Quality-improvement analytics
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American Journal of
Health-System
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consistency and prevent
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Decreased average LOS (not sigif)
but signif decrease in mortality;
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Implementation and
optimization of smart infusion
systems: Are we reaping the
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Journal for
Healthcare Quality

Trbovich, P.,
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Cafazzo, J., & Easty,
A.

The impact of traditional and
smart pump infusion
technology on nurse
medication administration
performance in a simulated
inpatient unit.

Quality & Safety in
Health Care

Winstead, E.,
Ratliff, P., Hickson,
R., Mueller, J., &
Judd, W.

Evaluation of an alternative
extended-infusion piperacillin–
tazobactam dosing strategy for
the treatment of gram-negative
infections.

International
Journal of Clinical
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Xamplas, R.,
Itokazu, G.,
Glowacki, R.,
Grasso, A.,
Caquelin, C., &
Schwartz, D.

Implementation of an
extended-infusion piperacillin–
tazobactam program at an
urban teaching hospital.

American Journal of
Health-System
Pharmacy

Yost, R. J., &
Cappelletty, D. M.

The retrospective cohort of
extended-infusion piperacillintazobactam (RECEIPT) study:
A multicenter study.

Pharmacotherapy

Experimental study to test smart
pump technology effects on
medication administration
safety. Recognizes
programming errors despite
hard limits of programmed drug
libraries.

24 nurses were observed using 3
types of pumps and 7 repeated
tasks (four intermittent and 3
continuous infusion tasks) so
each participant completed 21
infusion tasks.

Recognizes programming errors
despite hard limits of programmed
drug libraries.

To assess the clinical and
economic impact of a novel 3-h
extended-infusion piperacillin–
tazobactam dosing strategy for
the treatment of gram-negative
infections.

433 bed hospital in Kentucky;
retrospective cohort study before
and after implementation; 181
pts received pip/taz for at least 48
hrs.

Significantly (p=.002) reduced 30day readmission with 3hr extended
infusions of P/T

Emphasis on quality assurance
outcomes with institution of new
extended pip/taz protocol

RECEIPT Study (retrospective
cohort of extended infusion
pip/taz) with signif decrease in
hosp mortality; 359 adults;
multicenter retrospective
medical record review; 14
hospitals selected varied in size
and location to best represent
broad population.

The primary outcome was
mortality rate of the patients
receiving extended infusion
piperacillin-tazobactam versus
those receiving non-extended
infusion comparative antibiotics.

Extended pip/taz infusions
demonstrated decreased mortality in
the treatment of patients with gramnegative infections; Decreased
mortality p=.05 and decreased LOS
p<.01.
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Development and assessment
of an interactive training tool
to help reduce error rate
associated with shared infusion
volume management tasks

Dissertations &
Theses @ Library
and Archives
Canada

Purpose of study was to develop
and validate a training sim for
critical care nurses to enhance
decision-making regarding
infusion volume management;
intensive undertaking for 25
nurses at many levels. Trbovich
was the faculty lead.

>200 page dissertation with
complex simulation initiative to
enhance shared infusion volume
reasoning of 25 critical care
nurses.

More complex simulation tool for
critical care nurses but the
underlying infusion volume
management issues are the same.

Yusuf, E., Spapen,
H., & Piérard, D.

Prolonged vs intermittent
infusion of
piperacillin/tazobactam in
critically ill patients: A
narrative and systematic
review.

Journal of Critical
Care

Systematic review comparing
the effectiveness of extended
versus continuous pip/taz
infusions in Belgium. Moderate
level of evidence (1 high quality
RCT and at least 2 high quality
retrospective studies show
similar results) supporting the
prolonged or extended pip/taz
infusion as having better clinical
outcomes than with intermittent
infusions and should be
preferred for critically ill
patients.

The studies in the review were
global but the RCT was done in
the US (Lee et al 2012)

Excellent validation of extended
pip/taz as best practice! Moderate is
defined as level 2 of 1-5, 1 being the
highest.
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Quality Improvement of the Extended Antibiotic Infusion Administration Process:
A Self-Instruction Module
Introduction
Extended antibiotic infusions, primarily four-hour piperacillin/tazobactam
(Zosyn), were added to pharmacotherapy options at this hospital in 2010. Since then,
several issues have emerged that jeopardize intended patient outcomes to extended
infusion therapy. This project will pilot an educational initiative to inform nursing staff
on one unit of current best practice evidence affecting extended antibiotic infusion
management.
This self-instruction module will review time-dependent antibiotic use and current
administration issues. An intervention will be introduced to redefine the beginning of
extended infusions in relation to the patient and improve dose delivery for the duration
periods ordered. The most important part of this self-instruction module will be its
consistent application following completion. Please begin using this information
immediately to improve the delivery of four-hour piperacillin/tazobactam (Zosyn)
infusions for patients.
Purpose
The purpose of this instruction module is to improve the delivery of four-hour
piperacillin/tazobactam (Zosyn) infusions using nursing management and stewardship
strategies for consistent and compliant dose delivery needed by patients experiencing
infections.
Objectives
Upon completion of this self-instruction module, participants will be able to:
1. Corroborate time-dependent antibiotics and clinical benefits to patients.
2. Redefine the beginning of the medication infusion in relation to the patient’s
intravascular space.
3. Document the beginning of the medication infusion in relation to the patient’s
intravascular space.
4. Ensure the four-hour duration of extended infusions in relation to the patient’s
intravascular space.
Instructions
1. Review the self-instruction module at your convenience within the designated
two-week period: 2/28/18 through 3/14/18
2. Answer the post-instruction questions and sign the attestation form. Submit both
the test and attestation to Megan Swink by Wednesday, March 14, 2018.
3. Piperacillin/tazobactam infusion administration will be randomly monitored by
direct observation and interview for a four-week period to evaluate the
effectiveness of this instruction.
4. Complete an anonymous survey within four weeks of instruction to help improve
the content of this module. The survey link will be emailed to all unit nurses via
Survey Monkey.
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Why are extended antibiotic infusions important?
Dynamic issues associated with infection create unprecedented demands for
quality healthcare improvements and modifications. Prior to 2010, researchers found
extended antibiotic infusions to be an effective treatment option with astounding cost
savings.1-3 As global extended antibiotic use increased, significant correlations between
extended infusions, decreased mortality, and shortened lengths of stay have dominated
the literature.4-14 Advantages of extended infusions have clearly evolved beyond costsavings. Piperacillin/tazobactam is a broad spectrum antibiotic but is currently one of the
best defenses against gram negative infection. Extended piperacillin-tazobactam
infusions are most commonly selected to target susceptible hospital associated infections
such as fluoroquinolone-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae,
Escherichia coli, or carbapenem-resistant Enterobacteriaceae (CRE).1
Antibiotic therapy has historically been guided by bacterial susceptibility to a
certain antibiotic. Multi drug-resistant organisms (MDROs) to the most commonly used
antibiotics have resulted in the emergence of alternative dosing strategies, such as the
extended antibiotic infusion.1,5 Certain antibiotics have proven in vitro to be most
bactericidal when infused over an extended period, making them time-dependent
antibiotics.1,5,6,9 Minimal drug concentrations are needed to inhibit bacterial growth, but
concentrations must remain constant for an extended duration in the bloodstream to
effectively destroy bacteria. The time for effective bacterial killing established for
piperacillin/tazobactam is 50% duration of the dosing interval (or four of the eight hour
interval).1-3 Receiving the entire dose too quickly interrupts bacterial exposure to the
minimal inhibitory concentration (MIC) required to prevent bacterial growth (see Figure
1).1,5,6 Therefore, although a bacterial pathogen may be susceptible to an antibiotic and
the entire dose is administered, bacteria are given the opportunity to multiply between
antibiotic doses. In a study of 5000 patients with hospital associated pneumonia,
researchers found that three-hour piperacillin/tazobactam infusions were not as effective
as other beta-lactams; but all were more effective than 30-minute duration infusions.2
Administering time-dependent antibiotics too quickly has been associated with longer
hospital stays and with greater mortality.5,12
In a cohort study of 194 patients with pseudomonas infections, Lodise,
Lomaestro, and Drusano (2007) were the first to associate significant mortality and
length of stay benefits with extended piperacillin/tazobactam infusions. Falagas et al.
(2013) shared a meta-analysis reviewing fourteen studies of over 1200 patients and their
findings relating extended antibiotic infusions to clinical outcomes.
Piperacillin/tazobactam effectiveness was consistently enhanced with extended infusion
durations. Significantly decreased mortality and lengths of stay were demonstrated. These
findings continued to be corroborated by multiple researchers as extended infusions were
integrated into global healthcare settings.9-11,13,14
Once piperacillin/tazobactam has been ordered as an extended infusion, it is
critical that the infusion time begins when the antibiotic begins infusing into the patient’s
intravascular space. It is just as critical that the infusion duration continues to infuse
slowly into the bloodstream for the entire four-hour period.12,15 Alexander and Zomp
(2015) reported up to 60% of the piperacillin/tazobactam dose can be lost to residual dead
space volume. When the medication bag is empty, the dead space volume still contains a
significant amount of drug that must also infuse.
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What does this mean for nurses?
Stewardship
MDROs are the result of inconsistent and ineffective antibiotic usage.17 Antibiotic
stewardship refers to the deliberately organized interprofessional strategies to ensure
optimal antibiotic usage in combating infectious diseases, and includes unprecedented
nursing implications.16-21 The American Nurses Association (ANA) and CDC have
collaborated to emphasize the need for nursing involvement in antibiotic stewardship to
improve antibiotic use in healthcare settings.16 The CDC (2017) developed four core
actions, including stewardship, to guide professionals in combating antibiotic resistance.
The Joint Commission (2016) established a new standard for medication management
teams in hospitals as of January 1, 2017, specifically requiring antimicrobial stewardship
action in controlling MDROs. 22
Dead Space
Dead space refers to the volume of the intravenous infusion pathway a solution
travels from exiting its original container until reaching the patient’s intravascular space.8
Nurses manage dead space volume with every infusion. The amount of dead space is
most significant when the infusion volume is small (less than 100 mL) and rates are slow
(less than 20 mL/hour).15 Dead space must be completely displaced by
piperacillin/tazobactam before the medication arrives at the patient’s intravascular space.
Without this displacement, the slow rate of the extended infusion (12.5 mL/hour) creates
an infusion delay in reaching the patient of approximately two hours (see Figure 1).
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Infusion Delay Problem
Figure 1 Eight-hour Medication Frequency Timeline
Intended infusion administration:
0hr

2hr

4hr

6hr

50% MIC infusion for 4 hours
Piperacillin/tazobactam
50ml at 12.5ml/hr

8hr

No infusion for 4 hours

Duration problem with current infusion administration:

No medication
reaches patient
for approx. 2hrs
but is documented
as infusion time

Med reaches patient
and begins infusing
at intended rate

Period left to
nursing judgment
with inconsistent
actions

What is the solution?
There is a potential for significantly impacting patient benefits from extended
infusions just by adjusting the current administration process. The solution to the
practice problem involves redefining the beginning of the antibiotic infusion to get the
dose to the patient for the duration ordered. This redefinition follows the same concept as
administering an intravenous push medication. The intravenous medication doesn’t reach
the patient’s intravascular space until the dead space (fluid occupying the tubing) is
displaced by the medication. In addition, upon completion of the intravenous push, the
medication is not completely administered until a post-medication flush displaces the
residual medication still in the tubing. This same displacement principle can also be used
to guide redefining the beginning of the extended antibiotic infusion.
Redefinition Guideline
A patient’s infusion begins at the patient, not at the drip chamber of the
medication bag. A 25 mL medication redefinition bolus will displace the dead space
volume prior to beginning the antibiotic infusion. The pump will then need to be set to
deliver 25 mL less in total volume. A post-infusion flush will be delivered at the same
medication infusion rate until the tubing is cleared of medication. Using this process,
patients will receive the ordered amount of medication for the ordered duration at the
time documented in the EPR. This process is compatible with either continuous infusions
of intravenous fluids or saline locked devices.
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New Procedure: WITHOUT Continuous IV Fluid
Infusion Pathway:
(Backpriming is unnecessary when reusing dedicated tubing since tubing will be
primed.)
1. Prime the tubing with 25 mL of medication bolus as directed in Table 1 below.
[When hanging new tubing, backprime the new secondary tubing with NS before
spiking the new secondary bag to remove air for priming procedure.]
2. Set secondary VTBI for 25 mL less than secondary bag volume (to account for
priming).
3. Set primary VTBI for 25 mL (to flush infusion tubing following secondary
infusion).
Rate must be the same as the secondary medication rate because medication is
continuing to infuse during this flush.
4. The infusion is complete when the smartpump alarm signals completion of the
primary NS flush, a total duration of 4 hrs of intravascular exposure.
5. Disconnect the infusion pathway between extended infusions to enhance patient
mobility.
New Procedure: WITH Continuous IV Fluid
Same above except:
1. Verify compatibility with continuous fluids
2. Continuous fluids will be delivered simultaneously using a separate smartpump.
3. Connect infusion tubing to the continuous IV fluid tubing via the port closest to
the patient.
4. Optional to leave medication tubing connected during dormant intervals if
smartpumps share one pole.
Setting Summary
Program priming bolus of medication:
Rate 999 mL/hr with VTBI 25 mL (must occlude primary tubing during bolus)
Set secondary IVPB and Primary flush the same:
Rate 12.5 mL/hr with VTBI 25 mL
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Table 1
Medication Bolus Instructions
Nursing Action
Rationale
Hang the new medication container and open the The secondary medication is ready for
clamp.
infusion.
[Backpriming is only needed when hanging new
secondary tubing. Do not spike the new
medication bag during backpriming.]

[Spike medication bag after backpriming
new tubing to avoid adding any volume to
the new medication bag. This maintains
consistency of the priming bolus at 25 mL
and reduces the risk of error.]

Program a secondary IV fluid bolus rate at 999
mL/hr for a VTBI of only 25 mL.

This redefines the beginning of the
infusion as the patient’s intravascular
space rather than the secondary drip
chamber)
The rapid bolus rate will otherwise pull the
bolus from both the primary and secondary
containers, regardless of the lowered height
of the primary fluid. The priming bolus
must be pulled entirely from the IVPB to
begin the medication infusion at the
patient’s intravascular space.

Press run to prime the infusion tubing while
pinching the primary tubing closed
throughout the priming bolus. The 25 mL
priming bolus from the container to the patient
will take 90 seconds and the smartpump will
signal completion.

Reprogram the secondary infusion for the
ordered rate of the four-hour infusion.

The medication infuses at the rate ordered.

Reprogram the secondary infusion VTBI for the
amount in the container minus the 25 mL
redefinition bolus.

The medication infusion pathway has
already been primed with 25 mL of the
medication, leaving less in the bag.

The primary fluid flush can be programed at this
time. Set the primary fluid flush rate at the same
rate as the medication ordered for a VTBI of 25
mL.

The primary fluid flush clears the residual
medication from the tubing once the
secondary container is empty. Medication
continues to infuse at the ordered rate
during this time for up to two more hours.
The medication infuses at the dosage
ordered, for the duration ordered, in the
intravascular space as ordered.
Documentation supports the patient’s
intravascular space as the beginning of the
extended infusion.
The patient has received optimal
intravascular extended exposure to the
medication therapy as ordered.

Attach the setup to the patient’s access and press
run to begin the extended infusion.
Documentation indicates accurate infusion begin
and end times.
The infusion is complete when the smartpump
alarm signals completion of the primary fluid
flush after a total duration of four hours.
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Frequently Asked Questions & Answers
1. Should I do this bolus with all IVPBs?
No. Other IVPBs infuse faster and reach the patient quickly. It’s the slow rate of the
extended infusion and the dead space volume (25 mL) that creates the significant
infusion delay.
2. Could I just use a primary IV set for the infusion?
That would deliver the med to the patient but traps significant residual (34%) med
in the tubing at the end of the infusion. Repeated disconnections would be needed
to flush the line. In addition, the unidirectional valve apparatus in the primary
tubing differentiates the primary and secondary tubings for the pump. The
secondary tubing could not be used as a flush with this system.
3. What if I forget to occlude the primary line during the bolus?
You would see drops falling from both the primary and secondary bags meaning
you were diluting the medication prime of the tubing. Be sure to also limit the
VTBI to 25 mL!
4. Why do we prime the line with 25 mL?
This is the average of the 21-28 mL dead space volume of various tubings,
extensions, and catheters commonly used for infusion setups.
5. Why would the IVPB policy not apply to this infusion?
It is the slow rate creating the two-hour infusion delay for the patient. Longer
duration infusions must be managed differently, especially when rates are less than
the dead space volume.
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Post-test
Post Instruction Questions (Circle the correct answer and submit with the attestation
form.)
1. The most significant evidence supporting patient benefits from extended antibiotic
infusion therapy includes:
A. Decreased mortality and lengths of stay
B. Improved would healing and pain control
C. Reductions in leukocytosis and thrombocytopenia
D. Enhanced functional capacity and mental status.
2. Which statement describes the rationale for redefining the beginning of the extended
antibiotic infusion?
A. A patient’s infusion begins at the patient, not the secondary drip chamber.
B. Dead space volume between the secondary container and the patient creates the
potential for a significant infusion delay.
C. Time-dependent antibiotics need intravascular exposure time for effective
bactericidal activity.
D. All the above are correct.
3. In the redefinition process, what must the nurse be doing throughout the 90 second
bolus?
A. Monitoring patient response closely for any signs of adverse reaction or
hypersensitivity
B. No special intervention is needed during this time.
C. Pinching the primary tubing closed so the redefinition bolus is only pulled from
the secondary antibiotic container.
D. Pinching the secondary antibiotic tubing closed so the redefinition bolus is only
pulled from the primary container.
4. What would be the correct order of actions when administering extended antibiotic
infusions using the improved process?
A. Bolus, backprime, secondary infusion, primary fluid flush
B. Backprime, bolus, secondary infusion, primary fluid flush
C. Primary fluid flush, bolus, backprime, secondary infusion
D. Secondary fluid flush, primary infusion, bolus, backprime
5. The redefinition bolus only applies to extended antibiotic infusions because:
A. Dead space volumes are the same for all IVPB infusions so perhaps it should
apply to all.
B. Greater IVPB volumes infusing faster reach the patient much more quickly
without significant delays.
C. Small IVPB volumes and slow rates significantly delay the antibiotic from
reaching the patient.
D. Both B and C.
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Quality Improvement of the Extended Antibiotic Infusion Administration Process:
A Self-Instruction Module

Attestation Form

I have reviewed and understand the information provided in this self-instruction module.

Signature__________________________________________Date________________
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Appendix C
Extended Antibiotic Infusion Redefinition Project Staff Survey
DIRECTIONS: Please indicate your response to the questions below as follows:
1-Strongly Disagree 2-Disagree 3-Agree 4-Strongly Agree
I found the redefinition instructions easy to understand.

1 2 3 4

It took a reasonable amount of time to complete the self-instruction module.

1 2 3 4

My awareness of managing intravenous infusion volume is improved
1 2 3 4
following the self-instruction module.
My awareness of time-dependent antibiotics is improved following the
1 2 3 4
self-instruction module.
Upon completion of the self-instruction module, I feel comfortable
1 2 3 4
implementing the redefinition process independently.
The redefinition process improves extended antibiotic infusion therapy
1 2 3 4
for my patients.
I would recommend a system-wide implementation of the self-instruction
1 2 3 4
module for nurses.
Have you administered extended Zosyn since completing the self-instruction module? If so,
describe any problems or concerns you may have had implementing the redefinition process.

In three sentences or less, provide feedback on the overall self-instruction module and
implementation.
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Appendix D
Infusion Monitoring Results

SECONDARY
Appendix

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

DATE

RATE

SECONDARY
VOLUME

PRIMARY
RATE

PRIMARY
VOLUME

March 28, 2018
March 28, 2018
March 28, 2018
March 29, 2018
March 29, 2018
March 29, 2018
March 30, 2018
March 30, 2018
April 2, 2018
April 2, 2018
April 3, 2018
April 3, 2018
April 3, 2018
April 4, 2018
April 4, 2018
April 4, 2018
April 5, 2018
April 5, 2018
April 5, 2018
April 5, 2018
April 7, 2018
April 10, 2018
April 11, 2018
April 11, 2018
April 11, 2018
April 12, 2018
April 17, 2018
April 17, 2018
April 18, 2018

12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5
12.5

25
25
50
50
50
50
25
25
50
25
25
50
50
25
50
25
50
25
50
50
50
25
50
50
25
25
50
25
25

12.5
12.5
25
50
50
50
12.5
12.5
25
12.5
12.5
50
100
12.5
12.5
12.5
25
12.5
12.5
50
50
12.5
50
25
12.5
12.5
12.5
12.5
12.5

20
20
50
100
42
100
20
20
50
20
20
50
50
50
20
20
100
20
20
50
100
20
50
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50
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25

